Jill E. Wood

Discovery and SAR of Novel 2,3‐Dihydroimidazo[1,2‐<i>c</i>]quinazoline PI3K Inhibitors: Identification of Copanlisib (BAY 80‐6946)

William J. Scott, Martin Hentemann, R. Rowley et al. · ChemMedChem · 2016 · 117 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13

Comparative effects on bone mineral density of tibolone, transdermal estrogen and oral estrogen/progestogen therapy in postmenopausal women

Gordana M. Prelević, Clive I. Bartram, Jill E. Wood et al. · Gynecological Endocrinology · 1996 · 38 citations

Medicine, Endocrinology, Pharmacotherapy +17

Effect of 17beta-hydroxysteroid dehydrogenase type 2 inhibitor on bone strength in ovariectomized cynomolgus monkeys.

Bagi Cm, Jill E. Wood, Donald M. Wilkie et al. · PubMed · 2009 · 29 citations

Medicine, Biochemistry, Endocrinology +17

4,5-Disubstituted cis-pyrrolidinones as inhibitors of type II 17β-hydroxysteroid dehydrogenase. Part 3. Identification of lead candidate

Jill E. Wood, Cedo M. Bagi, Christiana Akuche et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 28 citations · Full text

Pharmacy, Biochemistry, Medicinal Chemistry +16

4,5-Disubstituted cis-pyrrolidinones as inhibitors of type II 17β-hydroxysteroid dehydrogenase. Part 2. SAR

David Gunn, Christiana Akuche, Jeremy L. Baryza et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 28 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +10